TERT and neoplasm: NGS analysis revealed that the tumor was negative for a BRAF mutation, but harbored putatively pathogenic variants in TP53 (p.Pro152TrpfsTer10; c.453_477del) and in the TERT promoter (C228T; c.-124C>T), and variants of uncertain clinical significance in PTCH1 (p.Ala4Thr; c.10G>A) and TSC2 (p.Gly1356Ser; c.4066G>A).